UMaine biotech start-up Neuright to be featured in March 15 Innovation Blender

Kristy Townsend, University of Maine alumna and former faculty member, and cofounder of Neuright Inc., will lead a discussion, “Neuright Inc. Tackles Peripheral Neuropathy — Catch It Early, Fix It Fast,” as part of the Innovation Blender series sponsored by MaineHealth Innovation and The Roux Institute.

Neuright is a UMaine biotech start-up and academic spin-out company that has commercialized a new patent-pending theragnostic medical device for peripheral neuropathy, a condition of nerve death in tissues and organs that is common with aging, diabetes, and more than 30 other diseases and disorders. Read more

Related Posts

Business Leaders: Deborah Bronk steers Bigelow Lab expansion to boost reach, programming

Deborah Bronk is president, CEO and a senior research scientist at Bigelow Laboratory for Ocean Sciences in East Boothbay, which will...

24 March 2025

UNE retains R2 Research status, reinforcing leadership in scientific advancement

The University of New England has retained its status as one of the country’s leading research universities with the recent release...

23 March 2025

Maine college students investigate health effects of forever chemicals

Two dozen Maine college students are investigating the public health effects of forever chemicals by using zebrafish as human stand-ins and...

21 March 2025